Ritesh Bhattacharjee was working as a dental oncologist in India when he met Raktim Bhattacharya, Ph.D., a Texas A&M associate professor in aerospace, electrical and computer engineering at the Dwight Look College of Engineering. In the course of their conversation, they discussed lockjaw—the inability to open the mouth widely—that resulted from radiation therapy for head and neck cancer.
When you break a bone, you get a cast and within a few months, your fracture heals. But what if you have a condition that impair bones' healing ability, such as the elderly, diabetic or osteoporotic? A team from engineering, medicine and veterinary medicine is using mesenchymal stem cells to heal bones faster and more effectively.
Prostate cancer tops the list of cancers in men, second only to skin cancer. According to the American Cancer Society, one out of seven men are diagnosed with prostate cancer, affecting more than 233,000 men each year and killing almost 30,000 annually. If caught early, prostate cancer is 90-95 percent curable, making screenings all the more important.
The future of cancer therapy may lie in the very stem cells that cause cancer in the first place. Researchers at the Texas A&M Institute of Biosciences and Technology are studying how stem cells that cause cancer come out of dormancy and become active. If they can keep the cells dormant, they can ultimately prevent cancer from forming.